Page last updated: 2024-09-05

sb 203580 and sb 218078

sb 203580 has been researched along with sb 218078 in 2 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(sb 218078)
Trials
(sb 218078)
Recent Studies (post-2010) (sb 218078)
3,48941,1371409

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)sb 218078 (IC50)
Serine/threonine-protein kinase Chk1Homo sapiens (human)0.015
G1/S-specific cyclin-E2Homo sapiens (human)0.68
cAMP-dependent protein kinase catalytic subunit alphaBos taurus (cattle)0.61
Cyclin-dependent kinase 1Homo sapiens (human)0.25
Cyclin-dependent kinase 4Homo sapiens (human)0.575
G1/S-specific cyclin-D1Homo sapiens (human)0.575
G1/S-specific cyclin-E1Homo sapiens (human)0.6333
Cyclin-dependent kinase 2Homo sapiens (human)0.6333

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1
Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A1

Other Studies

2 other study(ies) available for sb 203580 and sb 218078

ArticleYear
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
    The Biochemical journal, 2013, Apr-15, Volume: 451, Issue:2

    Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase

2013